Drug
Sabirnetug
Sabirnetug: highest development phase Phase 2, developed by Acumen Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Acumen Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| sabirnetug NCT06335173 | Phase 2 | Alzheimer Disease |
Latest
No recent events.
Follow Sabirnetug on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.